Sept 2013: Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (+JSMO)

open access (pdf)

text file

Newly diagnosed and relapsed epithelial ovarian
carcinoma: ESMO Clinical Practice Guidelines
for diagnosis, treatment and follow-up†

 on behalf of the ESMO Guidelines Working Group*
1UCL Cancer Institute, University College London, London; 2Imperial College, London, UK; 3MD Anderson Cancer Centre, Madrid, Spain; 4European Institute of Oncology,
University of Milan Bicocca, Milan, Italy; 5Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland
These Clinical Practice Guidelines are endorsed by the Japanese Society of Medical Oncology (JSMO)

 "The estimated number of new ovarian cancer cases in Europe in 2012 was 65 538 with 42 704 deaths [1]."